pain relief

Oral Surgeon Opioid Prescribing Habits in the US during 2016 to 2019

by

An interesting article titled “Opioid prescribing by oral and maxillofacial surgeons in the United States, 2016–2019” written by Tumader Khouj, Deborah E. Polk, and Katie J. Suda, appears in the October 9th, 2022, issue of the Journal of Public Health Dentistry. The article describes opioid prescribing trends among oral and maxillofacial surgeons (OMFS) in the United States during 2016 to 2019. In the past on this site several articles have covered opioid prescribing habits, see for example Assessing the Impact of Three Day Opioids Limits for Dentists, Insurance Companies Limiting Access to Opioids After Wisdom Teeth Surgery, Reducing Opioids in Oral and Maxillofacial Surgery, and Dentists Overprescribing Opioids to Adults in the U.S.. In the article, the authors conducted a retrospective analysis of IQVIA Longitudinal Prescription Dataset (LRx) from January 1, 2016, to December 31, 2019, that includes 92% of … Read more

Factors that Influence Opioid Prescribing After Teeth Removal

by

An interesting article titled “Factors influencing opioid prescribing after tooth extraction,” appears in the  Journal of the American Dental Association written by Douglas R. Oyler and et al. (published June 9, 2022). The article seeks to look at specific characteristics that infuence opioid prescribing after tooth extractions to help potentially lead to less opioid that are uncessarily prescibed. The subect of opioids and wisdom teeth extractions has been covered on this site frequently before, see for example the posts, Record Numbers Predicted to Die from Opioids in the US and Dentists Overprescribing Opioids to Adults in the U.S.. Patients in the U.S. are often first exposed to an opioid prescription from a dentist or dental care provider. Even so nowadays many dentists recommend nonopioid analgesics as the first option against pain reflief. In the article the authors reviewed records from … Read more

Visualization of Facial Pain Sensory Signaling

by

An interesting article titled “Visualization of trigeminal ganglion sensory neuronal signaling regulated by Cdk5,” written by M. Hu and et al. appears in the 2022 editon of Cell Reports (Mar 8, vol. 38, no. 10, pp. 110458). The article seeks to explore some of the mechanisms underlying facial pain and used intravital imaging to compare trigeminal neuronal activities after mechanical, thermal, and chemical stimulation. The work was carried out by researchers for the NIH’s National Institute of Dental and Craniofacial Research. Orofacial pain that occurs in the oral and facial region affects 5% to 12% of the U.S. population. This pain can affect daily activities and causes many to seek medications like opioids for releif, but opioids can be addicting. Thus researchers are interested in learning more about how facial nerves process pain signals to help lead to more efficeitn … Read more

Nonsteroidal anti-inflammatory drugs better than opioids for pain after dental extractions

by

An interesting article titled “Acute Postoperative Pain Due to Dental Extraction in the Adult Population: A Systematic Review and Network Meta-analysis,” written by A. Miroshnychenko and et. al appears in the 2023 edition of the Journal of Dental Research. The article seeks to conduct a systematic review and meta-analysis to assess tto compare the effectiveness of 10 different pharmacological treatments including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids, to the management of acute pain after dental tooth extractions. Further the article looked at the pain associated with pulpitis or its complications. The authors were motived to conduct the review based on the opioid crisis occuring in North America which has been discussed before on this site, see for example the posts Assessing the Impact of Three Day Opioids Limits for Dentists, Dentists Overprescribing Opioids to Adults in the U.S., and Reducing … Read more

Taking etoricoxib before Wisdom Teeth Surgery to Help Relieve Pain

by

An interesting article titled “Does low dose of etoricoxib play pre-emptive analgesic efect in third molar surgery? A randomized clinical trial” written by Long Xie and et al. appears in BMC Oral Health (vol. 21, no. 462, 2021). The article discusses the results of a randomized clinical trial that explored if a preemptive low dose of the nonsteroidal anti-inflammatory drug (NSAID) etoricoxib may reduce the need for analgesics after wisdom teeth extraction. The study the authors conducted was designed as randomized, parallel, double-blinded and placebo-controlled and occurred between August 2019 and July 2020. A total of 56 patients were included in the study that met the inclusion criteria and scheduled to have impacted horizontal mandibular wisdom teeth extracted. The authors found that the mean VAS pain score in the etoricoxib group was significantly lower than that in the placebo group … Read more